Article info

Download PDFPDF
Health-related quality of life in transfusion-dependent patients with myelodysplastic syndromes: a prospective study to assess the impact of iron chelation therapy

Authors

  1. Correspondence to Dr Fabio Efficace, Head, Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA), GIMEMA Data Center, Via Benevento, 6, –Rome 00161, Italy; f.efficace{at}gimema.it
View Full Text

Citation

Efficace F, Santini V, La Nasa G, et al
Health-related quality of life in transfusion-dependent patients with myelodysplastic syndromes: a prospective study to assess the impact of iron chelation therapy

Publication history

  • Received May 23, 2014
  • Revision received August 4, 2014
  • Accepted August 24, 2014
  • First published September 9, 2014.
Online issue publication 
February 11, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.